Recessive dystrophic epidermolysis bullosa (RDEB) is a rare and severe hereditary skin disease, caused by mutations in the COL7A1. However, whether non‐invasive prenatal testing (NIPT) can be used for this monogenic genodermatosis remains unknown. Accordingly, we conducted a study in which one couple at high risk of having a fetus with RDEB were recruited and tested by haplotyping‐based NIPT. Next‐generation sequencing‐based multi‐gene panel testing was carried out in this couple and their first child as proband who was affected with RDEB. We deduced parental haplotypes via single nucleotide polymorphism (SNP)‐based haplotype linkage analysis. Then the maternal plasma cell‐free DNA was also sequenced to determine the fetal haplotypes using a parental haplotype‐assisted hidden Markov model (HMM) analysis. Results show that the fetus was only a heterozygous mutation carrier in COL7A1 and the identical results were obtained after birth. These results demonstrate that haplotyping‐based NIPT is a feasible method for NIPT of RDEB.
Objective:
Neurofibromatosis type 1, resulting from NF1 mutation, is estimated to affect one in 3000 people worldwide. NF1 is a pathogenic gene with one of the highest mutation rates in humans. This study was aimed to report a case in which members of a Chinese family had two distinct NF1 variants.
Methods:
DNA was isolated from the peripheral blood of the proband and his wife and affected son. Whole-exome sequencing was performed on the proband, while next-generation sequencing was used to detect NF1 and other related genes in his wife and son. Sanger sequencing was conducted to confirm the variants.
Results:
An unreported variant c.6143T>G and a recurrent variant c.1063-2A>G of NF1 were identified in the proband and his affected son, respectively. The latter variant was not found in the peripheral blood lymphocytes of the proband and his wife. Paternity testing confirmed their parent-child relationship. We summarized the findings of similar reported cases.
Conclusion:
Our study described a rare phenomenon in which one Chinese family had independent NF1 variants. The findings indicate that clinicians need to sequence the whole NF1 gene of all family members rather than merely verifying the suspect variant detected in the proband.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.